AMBA up +4.33% percent right now. $AMBA High is at 49.32

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
AMBA up +4.33% percent right now. $AMBA High is at 49.32 and the Low 46.41 with current volume of 1,298,403.

Recent News posted below.

AMBA Ambarella Inc Recent Headline News

MagnaChip Aims for Internet of Things with New Technology - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 5:30PM CST
MagnaChip Semiconductor (MX) launched a new manufacturing process technology that will prove crucial to the growth of Internet of Things.
AMBA: 49.12 (+1.98), AXTI: 2.36 (-0.01), MX: 11.27 (-0.17), PSEM: 11.52 (-0.02)

Integrated Device Technology (IDTI) Jumps: Stock Rises 6.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:32AM CST
Integrated Device Technology, Inc. (IDTI) was a big mover last session, as the company saw its shares rise nearly 7% on the day.
AMBA: 49.12 (+1.98), AXTI: 2.36 (-0.01), FORM: 8.86 (+0.08), IDTI: 18.07 (+0.34)

Atmel Expands Energy Solutions Portfolio for Utility Industry - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 5:55PM CST
Atmel (ATML) unveiled a new family of wireless transceivers and also announced the launch of two new Power-line Communication (G3-PLC) solutions.
AMBA: 49.12 (+1.98), ATML: 7.54 (+0.10), AXTI: 2.36 (-0.01), PSEM: 11.52 (-0.02)

Top Funds Buy Ulta Beauty, Alexion, Avago
at Investor's Business Daily - Tue Nov 04, 5:52PM CST
Managers of leading mutual funds in recent months have continued to stock up on large medical stocks, such as Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Celgene (CELG), Jazz Pharmaceuticals (JAZZ),Allergan (AGN) and Centene (CNC). The...
AMBA: 49.12 (+1.98), MNST: 107.00 (-1.39), SWKS: 60.80 (+0.92), GMCR: 154.56 (+1.66), ILMN: 188.91 (+2.56), WSM: 66.48 (+0.60), NXPI: 74.32 (+0.78), CELG: 107.57 (+1.12), HAIN: 108.00 (+0.32), AGN: 195.69 (-0.31), CNC: 93.00 (+1.28), V: 249.54 (-2.89), CALM: 42.20 (-0.83), JAZZ: 172.49 (+1.69), ALXN: 193.71 (-0.10), LOW: 57.83 (+0.14), ULTA: 122.46 (+0.71), MA: 84.67 (-0.13), AVGO: 85.58 (+0.54), PETM: 72.34 (-0.20)

Stocks Fall Sharply; Probe Shakes JPMorgan
at Investor's Business Daily - Tue Nov 04, 11:07AM CST
Stocks fell in mixed volume Tuesday as sellers stepped forward aggressively for the first time in almost two weeks. The Nasdaq and the S&P 500 each trimmed 0.7%, while the Dow Jones industrial average eased 0.3%. Volume was running higher on the NYSE...
AMBA: 49.12 (+1.98), GPRO: 76.08 (-2.98), JPM: 61.70 (+0.23), PG: 89.19 (+0.06)

Apple, Alibaba Lead 5 Stocks Bolting To New Highs
at Investor's Business Daily - Mon Nov 03, 7:06PM CST
With the market in a confirmed uptrend, most stocks are heading higher. But which are the real leaders? Look for companies such as Apple (AAPL) that boast superior fundamentals whose stocks are outperforming the general market. Today's Screen Of The...
AMBA: 49.12 (+1.98), GPRO: 76.08 (-2.98), AMZN: 303.82 (+3.96), SWKS: 60.80 (+0.92), ALK: 56.05 (+0.91), UAL: 54.88 (+0.70), T: 35.11 (+0.20), SAVE: 78.73 (+1.42), EBAY: 53.77 (+0.26), GOOGL: 557.91 (+6.09), TASR: 18.94 (+0.42), AAPL: 109.01 (unch), VZ: 51.01 (+0.15), DGLY: 12.21 (+0.02), BABA: 117.07 (+2.51)

Stocks Finish Mixed As Oil Tumbles, Airlines Rise
at Investor's Business Daily - Mon Nov 03, 3:40PM CST
Stocks finished mixed Monday, deflating after a mild rally. Volume was lighter than Friday's hectic pace on both exchanges. The Nasdaq ended with a 0.2% gain; the Dow Jones industrial average dipped 0.1% and the S&P 500 was fractionally lower. The...
AMBA: 49.12 (+1.98), GPRO: 76.08 (-2.98), HA: 18.38 (+0.01), XOM: 96.41 (-0.18), ATHM: 44.02 (+0.39), UAL: 54.88 (+0.70), RYAAY: 61.18 (+0.55), SAVE: 78.73 (+1.42), Q: 57.35 (+0.14), LNKD: 227.71 (+4.67), CVX: 117.79 (-1.01)

Stocks Open Mixed And Quiet; Chipmakers In Motion
at Investor's Business Daily - Mon Nov 03, 9:35AM CST
Stocks wobbled in a mixed start Monday on a cross-current of company news and economic reports. The Nasdaq climbed 0.3% and the Dow Jones industrial average dipped 0.1%, but both moved in soft trade. The S&P 500 added a fraction. Volume was weak on...
AMBA: 49.12 (+1.98), LCI: 51.16 (+0.99), MU: 32.91 (-0.10), SWKS: 60.83 (+0.95), SAPE: 24.66 (-0.01), AFSI: 50.55 (+0.66), CRUS: 19.54 (-0.01), LH: 100.82 (+0.30), CVD: 100.63 (+0.11)

Critical Alerts For Mobileye NV, Schlumberger, Ambarella, Walter Energy and Inovio Pharmaceuticals Released By InvestorsObserver
PR Newswire - Mon Nov 03, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for MBLY, SLB, AMBA, WLT and INO.
AMBA: 49.12 (+1.98), INO: 10.79 (-0.44), WLT: 3.25 (+0.06), MBLY: 46.30 (-0.47), SLB: 99.25 (+0.52)

Silicon Image, Inc. (SIMG) in Focus: Stock Surges 16.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:21AM CST
Silicon Image, Inc. (SIMG) was a big mover last session, as the company saw its shares surge by nearly 17% on the day.
AMBA: 49.12 (+1.98), AXTI: 2.36 (-0.01), FORM: 8.86 (+0.08), SIMG: 5.41 (+0.07)

Stocks End Week On Fine Note; LinkedIn Surges On Earnings
at Investor's Business Daily - Fri Oct 31, 3:29PM CDT
The market enjoyed another shot of institutional buying Friday, cheered by additional -- and unexpected -- stimulus measures by the Bank of Japan. Another round of healthy earnings reports and a rise in U.S. consumer confidence also fueled positive...
AMBA: 49.12 (+1.98), TSLA: 241.43 (+1.23), GPRO: 76.08 (-2.98), ACT: 245.56 (-0.35), FRGI: 56.25 (+0.66), LNKD: 227.71 (+4.67), JAZZ: 172.49 (+1.69), FLT: 149.14 (-0.04), EPAM: 46.70 (-0.25), REGN: 382.08 (+4.24), BABA: 117.07 (+2.51)

Stocks Extend Gains After Bank of Japan Surprise Move
at Investor's Business Daily - Fri Oct 31, 10:51AM CDT
Stocks extended their gains going into the lunch hour Friday. Major indexes came out of the blocks at full sprint, thanks to an unexpected overnight announcement by the Bank of Japan to increase asset purchases to shore up the country's sagging...
AMBA: 49.12 (+1.98), GPRO: 76.08 (-2.98), XOM: 96.41 (-0.18), CVX: 117.79 (-1.01)

Microchip Misses on Q2 Earnings Despite Record Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 10:00AM CDT
Broad-based growth across all product lines helped Microchip Technology Inc. (MCHP) deliver record second-quarter fiscal 2015 revenues.
AMBA: 49.12 (+1.98), SUNE: 18.00 (-0.06), FORM: 8.86 (+0.08), MCHP: 43.37 (+0.23)

Stocks Surge At Starting Bell; Mylan, Expedia, GoPro Rocket
at Investor's Business Daily - Fri Oct 31, 9:36AM CDT
Stocks sprinted out of the starting gate Friday, with economic news, quarterly reports and international markets all adding lift. The Nasdaq staked out an early lead, up 1.2%, asMylan (MYL), Analog Devices (ADI) and Expedia (EXPE) all opened more...
AMBA: 49.12 (+1.98), GPRO: 76.08 (-2.98), EXPE: 86.02 (+0.91), ADI: 50.25 (+0.01), MYL: 53.74 (+0.63), MELI: 136.34 (+1.59)

Cavium (CAVM) Jumps: Stock Moves 7.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 7:57AM CDT
Cavium, Inc. (CAVM) was a big mover last session, as the company saw its shares rise over 7% on the day.
AMBA: 49.12 (+1.98), CAVM: 52.65 (-0.42), SUNE: 18.00 (-0.06), SIMO: 23.47 (-0.10)

Technical Recap on Semiconductors Equities - Canadian Solar, ARM Holdings, Maxim Integrated Products, Freescale Semiconductor, and Ambarella
PR Newswire - Fri Oct 31, 7:45AM CDT
Investor-Edge has initiated coverage on the following equities: Canadian Solar Inc. (NASDAQ: CSIQ), ARM Holdings PLC (NASDAQ: ARMH), Maxim Integrated Products Inc. (NASDAQ: MXIM), Freescale Semiconductor Ltd (NYSE: FSL), and Ambarella Inc. (NASDAQ: AMBA). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, October 30, 2014, the NASDAQ Composite ended at 4,566.14, up 0.37%, the Dow Jones Industrial Average advanced 1.30%, to finish the day at 17,195.42, and the S&P 500 closed at 1,994.65, up 0.62%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Information Technology Sector Index ended the day at 659.28, up 0.23%, with the index also advancing 1.49% in the previous three trading sessions. Register for your complimentary reports on these five stocks at:
AMBA: 49.12 (+1.98), MXIM: 29.68 (+0.09), ARMH: 41.84 (+0.40), FSL: 20.29 (+0.52), CSIQ: 31.55 (+1.28)

FormFactor (FORM) in Focus: Stock Moves 9.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 7:37AM CDT
FormFactor Inc. (FORM) was a big mover last session, as the company saw its shares rise more than 9% on the day.
AMBA: 49.12 (+1.98), PSEM: 11.52 (-0.02), FORM: 8.86 (+0.08), SIMO: 23.47 (-0.10)

Silicon Motion Tops Q3 Earnings on Solid Product Demand - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:50PM CDT
Silicon Motion Technology Corp. (SIMO) reported third-quarter 2014 results with non-GAAP earnings per ADS of 57 cents per share, handily surpassing the Zacks Consensus Estimate of 39 cents by 46.2%.
AMBA: 49.12 (+1.98), SUNE: 18.00 (-0.06), AOSL: 8.90 (+0.52), SIMO: 23.47 (-0.10)

Applied Micro Q2 Loss Narrows on Low Operating Expenses - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 9:50AM CDT
Applied Micro Circuits Corporation (AMCC) reported second-quarter fiscal 2015 non-GAAP net loss of $5.0 million or loss of 6 cents on a per share basis versus a net income of $2.0 million or 3 cents per share in the year-ago period.
AMBA: 49.12 (+1.98), SUNE: 18.00 (-0.06), AMCC: 6.35 (-0.11), AVGO: 85.58 (+0.54)

Stocks Stage Mixed Start; Facebook Drags Down Nasdaq
at Investor's Business Daily - Wed Oct 29, 9:31AM CDT
Stocks opened mixed Wednesday, with the Dow Jones industrial average up 0.3%, the S&P 500 up 0.2% and Facebook dragging the Nasdaq down 0.3%. Volume rose 38% on the Nasdaq and was 3% higher on the NYSE, compared to trade at the same time Tuesday. The...
AMBA: 49.12 (+1.98), GPRO: 76.08 (-2.98), V: 249.54 (-2.89), ORB: 24.43 (+0.19), BIDU: 246.89 (+10.35), GILD: 107.09 (+0.64), MET: 54.40 (-0.21), KRFT: 57.84 (-0.03)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 412

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 130

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 288

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 127

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Expanding Horizons: Future of IVD Contract Manufacturing

Updated Category News Views 117

The Growing Landscape of IVD Contract Manufacturing The in vitro diagnostics (IVD) contract manufacturing market is on the brink of significant expansion, anticipated to reach a staggering USD 39.74 billion by 2031. This growth represents a compounded annual growth rate (CAGR) of 11.60% from 2024 to 2031, driven chiefly by the needs of the healthcare industry to keep pace...

Continue Reading
Citi Upgrades AerCap Holdings Price Target to $117 Amid Strong Performance

Updated Category News Views 79

Citi Upgrades AerCap Holdings Price Target Citi has recently updated its outlook on AerCap Holdings (NYSE:AER), raising the price target to $117 from $113. This move reflects Citi's confident stance on the aircraft leasing company's financial health within the aviation sector. By reaffirming their buy rating, the firm signals strong expectations for AerCap's growth...

Continue Reading
LG Energy Solution Reports Strong Q2 2025 Financial Performance

Updated Category News Views 750

LG Energy Solution Achieves Remarkable Financial Milestones In a significant announcement, LG Energy Solution has revealed its performance for the second quarter of 2025, detailing impressive results that demonstrate the company's resilience and strategic focus on growth. With consolidated revenue of KRW 5.6 trillion and an operating profit of KRW 492.2 billion, the...

Continue Reading
Genpact Shines as a Leader in Sustainability Recognition

Updated Category News Views 264

Genpact's Sustainable Initiatives Gain Global Recognition Recently, Genpact (NYSE: G), an advanced technology services provider, received significant acclaim for its commitment to sustainability. Being featured in TIME's prestigious list of the World's Best Companies in Sustainable Growth for 2025 showcases their dedication to ethical business practices and innovation. A...

Continue Reading
Medical Express Ambulance Faces Data Breach Investigation

Updated Category News Views 344

Understanding the Data Breach Investigation Edelson Lechtzin LLP, a prominent class action law firm, is currently looking into data privacy concerns affecting customers of Medical Express Ambulance, Inc. (MedEx). MedEx has reported potential unauthorized access to its network, raising significant alarm regarding the safety of customer data. Medical Express Ambulance, Inc....

Continue Reading